(WASHINGTON) -- Eli Lilly has announced the U.S. government is buying an additional 150,000 courses of the only monoclonal antibody therapy left that still holds up against all COVID-19 variants of concern, including BA.2. The new purchase of the therapy, called bebtelovimab, is costing the government... Read More.
(WASHINGTON) -- Nationwide distribution of one of the last remaining monoclonal antibody treatments is being paused "effective immediately" since it has shown to be ineffective against the COVID-19 BA.2 subvariant now dominating every region of the country, an internal letter sent Tuesday afternoon from... Read More.
(NEW YORK) -- It's hard to imagine a time when treatments weren't available for COVID-19. Yet this was the case when the World Health Organization declared the virus to be a global pandemic in March 2020. There was a need to test both existing medicines and... Read More.
(WASHINGTON) -- The Food and Drug Administration has authorized a new monoclonal antibody treatment for COVID-19, shown to hold up against the omicron variant and BA.2 subvariant. The drug, called bebtelovimab from Eli Lilly, is a monoclonal therapy meant for COVID-19 patients as young as... Read More.
(NEW YORK) -- With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options that will stand up to the variant. The first oral antiviral treatment for the virus was authorized by the Food and Drug Administration Wednesday. Pfizer's... Read More.
(NEW YORK) -- Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from researchers and public health officials that the vaccines are safe an effective, a small and in some cases vocal minority of Americans are reluctant to... Read More.
(NEW YORK) -- The use of monoclonal antibodies as a way to prevent people from getting very sick with COVID-19 is rapidly increasing -- alongside the grim statistics on surging infection rates across the country. Federal health officials have seen a "significant increase" in the... Read More.
BY: DR. MIRANDA ROSENBERG, ABC NEWS (NEW YORK) — Antibody medicines like the one that earned President Donald Trump's praise after treatment earlier this month are not just for COVID-19. For the past 30 years, this type of... Read More.